IRX-related homeobox gene MKX is a novel oncogene in acute myeloid leukemia
2024

MKX Gene as a New Oncogene in Acute Myeloid Leukemia

publication 10 minutes Evidence: moderate

Author Information

Author(s): Nagel Stefan, Meyer Corinna, Pommerenke Claudia

Primary Institution: Dept. of Human and Animal Cell Lines, Leibniz-Institute DSMZ, Braunschweig, Germany

Hypothesis

The study investigates the role of the IRX-related homeobox gene MKX in normal and malignant hematopoiesis.

Conclusion

MKX is identified as a novel aberrantly expressed gene in acute myeloid leukemia and multiple myeloma, suggesting its potential as a therapeutic target.

Supporting Evidence

  • MKX is silent in normal hematopoiesis but aberrantly expressed in subsets of AML and MM.
  • Knockdown of MKX in OCI-AML3 cells reduced CCL2 expression, indicating its role in proliferation.
  • MKX activates CCL2, which promotes cell proliferation in AML.
  • MKX is regulated by transcription factors IRX5 and JUNB, and inhibited by GATA2 and STAT5.

Takeaway

The MKX gene, usually silent in healthy blood cells, is found to be active in some leukemia cases, which might help doctors find new ways to treat this disease.

Methodology

The study used bioinformatic analyses, RNA sequencing, and siRNA-mediated knockdown in AML cell lines to investigate MKX expression and its effects.

Limitations

The role of MKX in multiple myeloma remains unclear and requires further investigation.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0315196

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication